| DNA Market Cap History Table | ||||||||||||||||||||||||||||||||||||||
Below is a table of the DNA market cap history going back to 3/17/2022:
Also see: DNA Shares Outstanding History and DNA YTD Return |
As of 7/31/2026 Ginkgo Bioworks Holdings has a market cap of 448.06 million. Investors often follow the DNA market cap history to compare the size of the company over time.
This page shows DNA market capitalization trends over time, with 18 market cap datapoints presented, dating back to 3/17/2022.

| DNA Market Cap History Table | ||||||||||||||||||||||||||||||||||||||
Below is a table of the DNA market cap history going back to 3/17/2022:
Also see: DNA Shares Outstanding History and DNA YTD Return |
| DNA Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||
DNA Historical Market Cap: -36.24% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||
| DNA Stock Price Chart |
| About Ginkgo Bioworks Holdings Inc |
| Ginkgo Bioworks Holdings, Inc. operates as a horizontal platform for cell programming, providing end-to-end services for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Its segments include Cell Engineering and Biosecurity. The Cell Engineering consists of research and development services performed under collaboration and license agreements relating to its cell programming platform. Its cell programming platform includes two core assets: the Foundry, and Codebase. The Biosecurity segment consists of biomonitoring and bioinformatic testing products and services primarily provided to public health authorities. We show 18 historical shares outstanding datapoints in our DNA shares outstanding history coverage, used to compute DNA market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing DNA market cap history over the course of time is important for investors interested in comparing DNA's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of DNA versus a peer is one thing; comparing DNA market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like DNA can fluctuate over the course of history. With this page we aim to empower investors researching DNA by allowing them to research the DNA market cap history. |
| DNA Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: The Importance of Market Cap | |
|
| DNA Share Performance |
| Market Cap Peers |
| Ginkgo Bioworks Holdings (DNA) is categorized under the Materials sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
DNMR Market Cap History DOW Market Cap History DOX Market Cap History DRD Market Cap History DSWL Market Cap History DWDP Market Cap History EAF Market Cap History ECL Market Cap History ECVT Market Cap History EGO Market Cap History More Materials companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.